Edwards Lifesciences Other Charges increased by 2134.4% to $71.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2650.0%, from $2.60M to $71.50M. Over 4 years (FY 2021 to FY 2025), Other Charges shows a downward trend with a -13.2% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase suggests unexpected non-operating costs or one-time financial hits, which can negatively impact net income.
This metric captures non-operating financial expenses that do not fall under standard categories like interest or taxes....
Often found in the non-operating section of the income statement; peers may label these as 'other expenses' or 'sundry charges'.
hon_other_charges| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.40M | $1.40M | $1.40M | -$3.30M | $4.30M | -$2.00M | $5.80M | $1.60M | $2.50M | $6.60M | $3.60M | $5.70M | $2.00M | $27.90M | $33.30M | $2.60M | -$1.30M | $2.70M | $3.20M | $71.50M |
| QoQ Change | — | -68.2% | +0.0% | -335.7% | +230.3% | -146.5% | +390.0% | -72.4% | +56.3% | +164.0% | -45.5% | +58.3% | -64.9% | >999% | +19.4% | -92.2% | -150.0% | +307.7% | +18.5% | >999% |
| YoY Change | — | — | — | — | -2.3% | -242.9% | +314.3% | +148.5% | -41.9% | +430.0% | -37.9% | +256.3% | -20.0% | +322.7% | +825.0% | -54.4% | -165.0% | -90.3% | -90.4% | >999% |